Min Young Lee

Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells

Cha Kyung Youn, Seon Joo Park, Min Young Lee et al. · Biomolecules & Therapeutics · 2013 · 62 citations · Full text

P38 Mapk Signaling, Immunology, P38 Mapk +18

Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway

Eun Jeong Kim, Min Young Lee, Young Jin Jeon · Korean Journal of Physiology and Pharmacology · 2015 · 60 citations · Full text

Immunology, Immune Regulation, Innate Immunity +23

Silymarin Inhibits Cytokine-Stimulated Pancreatic Beta Cells by Blocking the ERK1/2 Pathway

Eun Jeong Kim, Jeeho Kim, Min Young Lee et al. · Biomolecules & Therapeutics · 2014 · 22 citations · Full text

Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor (<i>EGFR</i>) activating mutation(s).

Tony Mok, Kazuhiko Nakagawa, Rafael Rosell et al. · Journal of Clinical Oncology · 2013 · 14 citations

Phase Ii Data, Open Label Study, Medicine +13

Factors controlling massive green tide blooms on the coasts of Jeju Island, Korea

Yujeong Choi, Kyungsun Yang, Min Young Lee et al. · Marine Pollution Bulletin · 2022 · 12 citations